What is Eko Devices?
Eko Devices is a health technology company focused on revolutionizing cardiovascular disease management. Founded in 2013 and headquartered in Oakland, California, Eko offers a comprehensive platform that includes non-invasive cardiac screening devices, care coordination software, and advanced machine learning algorithms. This integrated approach enables healthcare providers to effectively screen, diagnose, and manage cardiovascular conditions, aiming to improve patient outcomes and streamline clinical workflows. The company's commitment to innovation positions it as a key player in the digital health and medtech industries.
How much funding has Eko Devices raised?
Eko Devices has raised a total of $163M across 6 funding rounds:
Angel/Seed
$20K
Private Equity
$2M
Series A
$5M
Series B
$20M
Series C
$95M
Series D
$41M
Angel/Seed (2013): $20K with participation from Hub Ventures
Private Equity (2015): $2M led by Founder.org
Series A (2018): $5M supported by ARTIS Ventures
Series B (2019): $20M featuring 3M Ventures, Seraph Group, Mayo Clinic, XTX Ventures, ARTIS Ventures, NTT Venture Capital, and DigiTx Partners
Series C (2022): $95M backed by DigiTx Partners LLC, 3M, Questa Capital Management LLC, Artis Ventures, NTT Venture Capital, and Highland Capital Partners Inc
Series D (2024): $41M with participation from Highland Capital Partners, ARTIS Ventures, Nttvc, and Questa Capital
Key Investors in Eko Devices
Highland Capital Partners
Highland Capital Partners is a venture capital firm known for investing in innovative startups. With a significant track record of successful exits and IPOs, they manage substantial assets and partner with entrepreneurs to foster business growth.
ARTIS Ventures
ARTIS Ventures is a venture capital firm that specializes in early-to late-stage investments, with a notable early investment in YouTube. They focus on dynamic companies and have a history of backing successful tech and biotech ventures.
Nttvc
NTTVC is a venture capital firm committed to supporting founders building a better future. They emphasize partnership and integrity, investing in innovative companies across various industries and providing capital alongside expertise and network support.
What's next for Eko Devices?
With the recent major strategic investment, Eko Devices is poised for accelerated expansion and further development of its technology. The company is likely to focus on scaling its commercial operations, enhancing its AI-driven capabilities for predictive diagnostics, and broadening its market reach. This infusion of capital will support Eko's mission to transform cardiovascular care by making advanced screening and management tools more accessible to healthcare providers globally. Future growth may involve strategic partnerships and continued innovation in remote patient monitoring and digital therapeutics.
See full Eko Devices company page
